WHO issues global epidemic risk warning

2 September 2007

The World Health Organization has warned that with 2.1 billion airline passengers flying each year, the risk of a major epidemic, such as Severe Acute Respiratory Syndrome or Ebola fever, is increased. The Geneva, Switzerland-headquartered international agency called for greater cooperation between governments to identify the onset and track the progression of epidemics.

A key element of any international effort to overcome epidemics is the sharing of data, a problem that has come to light recently with the reluctance of Chinese authorities and the outright refusal of the Indonesian government, to share avian influenza virus samples (Marketletters passim).

The WHO's latest report, A Safer Future, claims that new diseases are emerging at a rate of one per year. The UK's public broadcaster, the BBC, reports that since the 1970s, 39 new diseases have appeared, with 1,100 epidemics monitored by the WHO in the past five years alone. The agency added that about half of the outbreaks recorded were initially brought to its attention by media reports and not national governments' public health authorities.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight